Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated at StockNews.com

StockNews.com assumed coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a report issued on Thursday. The brokerage set a “sell” rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of Ampio Pharmaceuticals stock opened at $0.00 on Thursday. The company has a market capitalization of $2,383.50, a PE ratio of 0.00 and a beta of 3.66. Ampio Pharmaceuticals has a one year low of $0.00 and a one year high of $2.47. The company has a 50-day simple moving average of $0.01 and a two-hundred day simple moving average of $0.01.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.